HOME >> MEDICINE >> NEWS
AAPS announces AAPS PharmSciTech, the association's second online journal

Alexandria, VA - The American Association of Pharmaceutical Scientists (AAPS) announces the launch of its newest exclusively online journal, AAPS PharmSci Tech,www.pharmscitech.com. The first issue of the journal will be published in the first quarter of 2000.

AAPS PharmSciTech covers the basic and applied research on pharmaceutical dosage forms, both traditional and novel, including the emerging area of biopharmaceuticals. The goal of the journal is to disseminate scientific and technical information on drug product design, development, evaluation and processing worldwide, taking full advantage of web publishing.

The journal invites manuscripts in all areas of pharmaceutical product development and manufacture, including pharmaceutical excipient evaluation, with a focus on practical (industrial) applications to research-based efforts. Specialty areas to be covered include, but are not limited to:

  • Preformulation Studies
  • Formulation Strategies and Stability Assessment
  • Design and Evaluation of Novel Drug Delivery Systems
  • Pharmaceutical Engineering and Technology Transfer
  • Standardization and Quality Improvement of Pharmaceutical Dosage Forms

Papers can be submitted at www.pharmscitech.com. To submit a manuscript for consideration, contact the AAPS PharmSciTech manuscript coordinator at pharmscitech-edoffice@aaps.org or Paul Clark at 703-518-8448.

Patrick P. DeLuca, Ph.D., Professor of Pharmacy and Chair of the Faculty of Pharmaceutical Sciences at the University of Kentucky College of Pharmacy, was named AAPS PharmSciTech's editor-in-chief. Dr. DeLuca, an AAPS Fellow and founding member, is a past president and Fellow of the APhA Academy of Pharmaceutical Sciences. He is the author or co-author of more than 165 research articles and book chapters and the recipient of the first AAPS Research Achievement Award in Pharmaceutical Technology.

"AAPS PharmSci Tech will provid
'"/>

Contact: Debbie Mierke
mierke@aaps.org
703-518-8442
American Association of Pharmaceutical Scientists
13-Jan-2000


Page: 1 2

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. ASGE announces grant recipients in annual research awards program
4. Novartis announces collaboration with Bayer for EMSELEX
5. American College of Chest Physicians announces new Critical Care Institute
6. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
7. Department of Energy announces new agreement with USC, national labs and private company
8. ACP announces international medical fellowship
9. St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
10. St. Jude Medical announces PAVE and DINAMIT clinical trial results
11. National Inventors Hall of Fame announces 2004 class of inventors

Post Your Comments:
(Date:6/20/2013)... Michigan-based natural health and wellness ... David R Hamilton which revealed that performing random acts ... in the release of the feel-good hormone Oxytocin in ... known as the ‘cardio protective’ hormone because it temporarily ... heart health. , “Being kind is something we can ...
(Date:6/20/2013)... Creighton University was named ... Roll – the highest federal recognition a college or ... service learning and civic engagement as well as meaningful ... for National and Community Service, is given to 690 ... foundation at Creighton is based on spiritual growth through ...
(Date:6/19/2013)... Paleo Burn has finally been released after much ... body they desire with no fad diets, pills, or extreme ... food products, Ken Smith was bold enough to expose the ... automatic, and permanent solution for weight loss. , ... a quick review of Paleo Burn, TotalWellnessCleanse.net believes this guide ...
(Date:6/19/2013)... Go Classy Tours has the reputation for ... over 25 Years. These resorts, draw many clients from ... bars and nude hot tubs. Grand Lido Negril was ... SuperClubs re-branded the resort to a Breezes and dis-continued the ... the Resort fell off dramatically. "Groups just went to ...
(Date:6/19/2013)... According to Fastcare , ... exposure is perhaps the biggest and certainly most ... is just one of many potential factors that ... Other risk factors include:, ,     Exposure ...     Heredity may play a role , ...
Breaking Medicine News(10 mins):Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3
(Date:6/19/2013)... SANTA CLARA, Calif. , June 19, 2013 ... and control solutions for life sciences process applications, ... 3L glass bioreactors for upstream cell culture and ... in a new product family of Finesse bioreactors ... R&D and cGMP applications.  They are fully compatible ...
(Date:6/19/2013)... , June 19, 2013   Voices Against ... finding a cure for brain cancer, today announced that ... grant to support the clinical investigation of Toca 511 ... high grade glioma brain cancer (Grade 3 or Grade ... novel treatments for advanced cancer, with an initial focus ...
(Date:6/19/2013)... 19, 2013 ... DrugPatentWatch to its extensive list of ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) , ... pharmaceutical, drug patents and their expirations. ... business functions of patent agents and ...
Breaking Medicine Technology:Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Drug Patent Watch 2Drug Patent Watch 3
Cached News: